John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP

  • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

    BMJ Date published:

  • Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial

    The Lancet Neurology Date published:

  • An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event

    The European Journal of Health Economics Date published:

  • Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial

    Kidney International Date published:

  • Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

    New England Journal of Medicine Date published:

  • INTRODUCTION

    Clinical and Experimental Pharmacology and Physiology Date published:

  • ADVANCES IN REDUCING THE BURDEN OF VASCULAR DISEASE IN TYPE 2 DIABETES

    Clinical and Experimental Pharmacology and Physiology Date published:

  • APOE genotype, ethnicity, and the risk of cerebral hemorrhage

    Neurology Date published:

  • Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes: Baseline results from the ADVANCE Retinal Measurements (AdRem) study

    Diabetes Care Date published:

  • JOINT EFFECTS OF BLOOD PRESSURE LOWERING AND GLUCOSE CONTROL IN THE ADVANCE TRIAL

    Date published:

  • INDEPENDENT IMPACT OF ALBUMINURIA AND KIDNEY FUNCTION ON CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES: RESULTS FROM THE ADVANCE TRIAL

    Date published:

  • RENOPROTECTION WITH PERINDOPRIL-INDAPAMIDE BELOW CURRENT RECOMMENDED BLOOD PRESSURE TARGETS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: RESULTS OF THE ADVANCE TRIAL

    Date published:

  • Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: Results of the ADVANCE trial

    Date published:

  • EARLY INTENSIVE BLOOD PRESSURE LOWERING ENHANCES HAEMATOMA RESOLUTION BUT DOES NOT AFFECT PERIHAEMATOMA OEDEMA: THE INTENSIVE BLOOD PRESSURE REDUCTION IN ACUTE CEREBRAL HAEMORRHAGE TRIAL (INTERACT) STUDY

    Date published:

  • The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

    BMJ Date published:

  • Intensive glucose control in type 2 diabetes - Reply

    New England Journal of Medicine Date published: